At the Damon Runyon Cancer Research Foundation, we fund high-risk, high-reward cancer research. We identify and enable young scientists who are brilliant, brave and bold enough to go where others haven’t.
Experimental monoclonal antibody therapy for advanced pancreatic cancer shows promising phase 1 results
Damon Runyon Cancer Research Foundation Awards $2.65M to Innovative Early Career Scientists
Understanding melanoma subtypes provides insights on treatment options
100% of donations fund cancer research.
Read 
